Exudative AMD and Cancer: Is there a clinically relevant connection in the comorbidity of these two diseases in patients treated with anti-VEGF agents for exudative AMD?
Researchers
- Associate Professor Riccardo Natoli Natoli (Primary Investigator)
- Chandrakumar Balaratnasingam (Secondary Investigator)
- Dr Nilisha Fernando (Secondary Investigator)
- Randev Mendis (Secondary Investigator)
- Professor Jan Provis (Secondary Investigator)
Grant status
CompletedGrant start date
09/03/2018Grant funding
- 2018: $10,000 from Bayer Australia Ltd
